Author/Contributor "France." Remove constraint Author/Contributor: "France." Call number LC Classification|R - Medicine (General)|RS - Pharmacy & Materia Medica Remove constraint Call number: LC Classification|R - Medicine (General)|RS - Pharmacy & Materia Medica

%{search_type} search results

9 catalog results

RSS feed for this result

1. Proceedings of the XIIIth International Symposium on Medicinal Chemistry, Paris, 1994 [1995]

Description
Book — 686 p. : ill. ; 25 cm.
Online
SAL3 (off-campus storage)

2. Drug safety : progress and controversies : proceedings of the IVth International Congress of Pharmaceutical Physicians = Sécurité et médicament : progrès et controverses : comptes rendus du IVe congrès international des médecins de l'industrie pharmaceutique [1982]

Description
Book — 1 online resource (xviii, 308 pages) : illustrations
Summary
  • Front Cover; Copyright Page; Drug Safety: Progress and Controversies; Table of Contents; PREFACE; ALLOCUTION DE BIENVENUE; Introduction; PART I: DRUG SAFETY: A MULTIFACETED PROBLEM DIVERSITE DES PROBLEMES POSES PAR L'EVALUATION DE LA SECURITE ENMATIERE DE MEDICAAIENTS;
  • Chapter 1. The Scientific Basis of Drug Safety Regulations; HOW CAN DRUG SAFETY BE REGULATED?; DO DRUG SAFETY REQUIREMENTS IMPEDE DRUG INNOVATION?; WHAT IS THE SIGNIFICANCE OF THE BENEFIT-TO-RISR RATIO?; WHERE ARE THE LIMITS OF SAFETY REGULATIONS?; CAN CLINICAL TRIALS BE EXPEDITED WITHOUT NEGLECTING DRUG SAFETY?
  • HOW CAN THE SCIENTIFIC BASIS OF DRUG SAFETY BE IMPROVED?REFERENCES;
  • Chapter 2. The Effects of Drug Regulation on Iatrogenic Disease; Abstract; A FOLLOW-UP STUDY OF REJECTIONS; A RETROSPECTIVE STUDY OF RESTRICTIVE DECISIONS; MAJOR IATROGENIC ACCIDENTS IN RETROSPECT; EFFICIENCY OF REGULATORY ACTIVITY ON SAFETY MATTERS; OTHER TECHNIQUES; AN INVALID TECHNIQUE; CONCLUSIONS; REFERENCES;
  • Chapter 3. Deregulation of Drug Development: If Effective, Can it be Safe?; Abstract; THE EARLY STAGES : LESS-STHINGENT CONTROL; SEQUENTIAL SUBMISSION AND REVIEW; REALISTIC STANDARDS OF EVIDENCE FOR EFFICACY.
  • ACCEPTANCE OF FOREIGN AND IRREGULAR DATAIMPROVED ADMINISTRATIVE AND MANAGEMENT TECHNIQUES; POSTMARKETING ISSUES; CONCLUSIONS; REFERENCES;
  • Chapter 4. Les grainds médicaLinents d'hier auraient-ils franchi avec succes le bairrage de la réglementation préclinique actuelle?; Resume; LES COMMISSIONS D'AGREMENT; LE PRIX ET LA DURÉE DES ESSAIS PRÉCLINIQUES; LES LABORATOIRES DE RECHERCHE PHARMACEUTIQUE; QUELQUES DOSSIERS DE GRANDS MEDICAMENTS ANCIENS; CONCLUSIONS; REFERENCES;
  • Chapter 5. The Intemationad Transfer of Information Regarding Drug Saifety : Benefits, Difficulties and Solutions; Abstract.
  • Chapter 6. Ethicad Considerations in Drug Saifety EvaduationAbstract; CONFLICT OF INTEREST IN RESEARCH; ETHICAL ISSUES IN CLINICAL DRUG TRIALS; THE MARKETING AND USE OF DRUGS; DRUGS IN T H E THIRD WORLD; THE CARE AND FEEDING OF PHARAiACEUTICAL PHYSICIANS; REFERENCES;
  • Chapter 7. A Compairisoii of International Guidelines for the Clinicad Evaduation of Psychotropic Drugs The Price of Safety; Abstract;
  • Chapter 8. USA et FDA Versus CEE et CSP Une etude comparative ouverte des medicaments anti-aingoreux; Resume.
  • PART II:POST MARKETING SAFETY ASSESSMENT INTERET ET LIMITES DES METHODES D'EVALUATION CLINIQUE DES EFFETS INDESIRABLES DES MEDICAMENTS APRES MISE SUR LE MARCHE: PRESENT METHODS
  • Chapter 9. Spontaneous Notification; Abstract; DEFICIENCIES OF PRE-MARKETING TESTS; PRESCRIBING CONDITIONS; ADR REGISTERS IN PMS; ADVANTAGES AND DISADVANTAGES; SPONTANEOUS REPORTING AND IDENTIFICATION OF A NEW HAZARD; RELATIVE RISKS OF VARIOUS DRUGS; ADR'S AND IN-DEPTH STUDIES; WHEN AND WHAT TO REPORT; FEEDBACK OF INFORMATION; CONCLUDING REMARKS; REFERENCES.
Online

3. Natural products as medicinal agents : plenary lectures of the International Research Congress on Medicinal Plant Research, Stasbourg, July 1980 [1981]

Description
Book — 526 p. : ill. ; 24 cm.
Online
SAL3 (off-campus storage)

4. Drug measurement and drug effects in laboratory health science [print] : fourth International Colloquium on Prospective Biology, Pont-à Mousson, October 2-7, 1978 [1980]

Description
Book — vii, 267 pages : illustrations ; 25 cm
Online
Medical Library (Lane)

5. Drug interference and drug measurement in clinical chemistry [print] : proceedings of the Third International Colloquium on Prospective Biology, Pont-à-Mousson, October 6-10, 1975 [1976]

Description
Book — 207 pages : illustrations ; 25 cm
Online
Medical Library (Lane)

6. Production of biologicals from animal cells in culture [1991]

Description
Book — 1 online resource (xxv, 826 pages) : illustrations
Online

7. Codex medicamentarius gallicus : pharmacopée française rédogée par ordre du gouvernement [1927]

  • Paris : Masson et cie, 1927.
Description
Book — xxii pages, 1 leaf, 999 pages ; 25 cm
Online
Medical Library (Lane)

8. Le médicament en nivernais au XIXe siècle [2004]

  • Thuillier, Guy.
  • Paris : Association pour l'étude de l'histoire de la sécurité sociale, c2004.
Description
Book — 634 p. : ill. ; 24 cm.
Online
SAL3 (off-campus storage)

9. A cordiall water : a garland of odd & old receipts to assuage the ills of man & beast [1981]

Description
Book — 142 p. ; 19 cm.
Online
SAL3 (off-campus storage)

Articles+

Journal articles, e-books, & other e-resources
See article+ results

Guides

Course- and topic-based guides to collections, tools, and services.
Search ""France."" in all guide pages